KALA PHARMACEUTICALS INC
COM · CUSIP 483119103
1
institutional holders
-2 vs Q1 2026
3
shares reported held*
$5reported value*
0 new
0 added
1 reduced
2 sold out
net sold ≈ $502 (-301 shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.67.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 56 |
| Q4 2022 | 3 |
| Q1 2023 | 2 |
| Q2 2023 | 3 |
| Q3 2023 | 1 |
| Q4 2023 | 1 |
| Q1 2024 | 1 |
| Q2 2024 | 1 |
| Q3 2024 | 1 |
| Q4 2024 | 1 |
| Q1 2025 | 2 |
| Q2 2025 | 2 |
| Q3 2025 | 2 |
| Q4 2025 | 3 |
| Q1 2026 | 3 |
| Q2 2026 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 0 | 0 |
| Q4 2024 | 0 | 0 |
| Q1 2025 | 1 | 0 |
| Q2 2025 | 0 | 0 |
| Q3 2025 | 0 | 0 |
| Q4 2025 | 1 | 0 |
| Q1 2026 | 1 | 1 |
| Q2 2026 | 0 | 3 |
Biggest buyers
| None |
Biggest sellers
| Cheviot Value Management, LLC | Sold out | -153 |
| HARBOUR INVESTMENTS, INC. | Reduced | -147 |
| Parallel Advisors, LLC | Sold out | -1 |
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| HARBOUR INVESTMENTS, INC. 0.00% of their portfolio | 3 $5 | Reduced -147 |